Gallium-68-THP PSMA(NanoMab)

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameGallium-68-THP PSMA(NanoMab)
Drug Alias NameNM-03
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIonising radiation emittersPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanomab
China Registration ClassN/A

Develop Information

Active CompaniesNanomab
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A